XOMA. Bull or Bear? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear?

XOMA 26.67

-10.7%

Jan 12 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Cacaito who wrote (10576)	6/29/1999 9:49:00 AM
From: aknahow	Read Replies (1) of 17367

So much we don't know. I would hope the commitment to spend on development is far more than the $5 to $10 you mentioned. I would hope it is on the order of $50 million over a maximum 5 year period. I hope the royalty is in the double digits and at least 25%. I must admit I don't understand how one can buy biotech stocks or should buy them when this crucial information is not generally provided. Those who preach that it's the science are wrong! It's also the business. A great science without great deals means nothing good for the shareholders. Sure without the science there is NADA also. Well I never guessed the partner would be Allergan. Who do you think the Mycoprex partner will be?

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next